Skip to main content
. 2022 May 25;15(6):656. doi: 10.3390/ph15060656
123I-mIBG 123I-meta-iodobenzylguanidine
ACE-I angiotensin-converting enzyme inhibitors
ACS acute coronary syndrome
ARB angiotensin receptor blockers
ARNI angiotensin-receptor neprilysine-inhibitor
BNP brain natriuretic peptide
β-AR β-adrenergic receptors
CHF chronic heart failure
CZT Cadmium–Zinc–Telluride
FBBG Flubrobenguane
ICD implantable cardioverter defibrillator
HED hydroxyephedrine
HFPEF heart failure with preserved ejection fraction
HFREF heart failure with reduced ejection fraction
HRV heart rate variability
H/M heart-to-mediastinum ratio
LBBB left bundle branch block
LVEF left ventricular ejection fraction
LVESV left ventricular end systolic volume
MAO monoamine oxidase
MPI myocardial perfusion imaging
NE norepinephrine
NET norepinephrine transporter
NYHA New York heart association
OMT optimal medical therapy
ROI region-of-interest
SCD sudden cardiac death
SDS summed defect score
SGLT2 inhibitor sodium-glucose cotransporter-2 inhibitor
SPECT single-photon emission tomography
TCM takotsubo cardiomyopathy
WO washout